177 related articles for article (PubMed ID: 6707919)
1. Characterization of the neurogenic vasodilatation elicited by central dopamine receptor stimulation with pergolide.
Lokhandwala MF; Kivlighn SD; Jandhyala BS
J Pharmacol Exp Ther; 1984 Mar; 228(3):696-703. PubMed ID: 6707919
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological analysis of the actions of SKF 82526 on cardiovascular dopamine receptors.
Lokhandwala MF; Watkins HO; Sabouni MH; Alkadhi KA
J Pharmacol Exp Ther; 1985 Aug; 234(2):337-44. PubMed ID: 2862275
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
[TBL] [Abstract][Full Text] [Related]
4. Central and peripheral dopaminergic mechanisms in the cardiovascular actions of pergolide in neurogenic hypertensive dogs.
Barrett RJ; Lokhandwala MF
Eur J Pharmacol; 1983 Dec; 96(3-4):211-26. PubMed ID: 6676105
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the role of alpha-1 and alpha-2 adrenoceptors in the maintenance of neurogenic tone to the hindlimb vasculature.
Hamed AT; Jandhyala BS; Lokhandwala MF
J Pharmacol Exp Ther; 1986 Aug; 238(2):599-605. PubMed ID: 3016243
[TBL] [Abstract][Full Text] [Related]
7. Effects of cerebroventricular administration of ouabain on renal hemodynamics in anesthetized dogs: evidence for the participation of renal dopaminergic vasodilator fibers.
Hom GJ; Jandhyala BS
J Pharmacol Exp Ther; 1984 Aug; 230(2):275-83. PubMed ID: 6747837
[TBL] [Abstract][Full Text] [Related]
8. Involvement of central dopamine receptors in the hypotensive action of pergolide.
Jadhav AL; Willett RN; Sapru HN; Lokhandwala MF
Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):281-6. PubMed ID: 6664381
[TBL] [Abstract][Full Text] [Related]
9. Presynaptic dopamine receptor stimulation in the cardiovascular actions of lergotrile.
Barrett RJ; Lokhandwala MF
J Pharmacol Exp Ther; 1981 Jun; 217(3):660-5. PubMed ID: 6112262
[TBL] [Abstract][Full Text] [Related]
10. Different dopamine receptor subtypes mediate the neurogenic vasodilation produced by fenoldopam and SK & F 85174 in the dog hindlimb.
Lokhandwala MF; Watkins HO; Dlewati A
Eur J Pharmacol; 1987 Nov; 143(3):383-90. PubMed ID: 2891555
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic inhibition of cardiac sympathetic nerve function by pergolide.
Barrett RJ; Lokhandwala MF
Eur J Pharmacol; 1982 Jan; 77(1):79-83. PubMed ID: 6277657
[TBL] [Abstract][Full Text] [Related]
12. Systemic hemodynamic and regional blood flow effects of LY141865, a selective dopamine receptor agonist.
Hahn RA; MacDonald BR
J Pharmacol Exp Ther; 1984 Sep; 230(3):558-68. PubMed ID: 6470973
[TBL] [Abstract][Full Text] [Related]
13. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
14. Presynaptic dopamine receptor stimulation and the antihypertensive action of pergolide in experimental neurogenic hypertension.
Barrett RJ; Lokhandwala MF
Proc West Pharmacol Soc; 1982; 25():39-42. PubMed ID: 7122527
[No Abstract] [Full Text] [Related]
15. Primate cardiovascular responses mediated by dopamine receptors: effects of N,N-di-n-propyldopamine and LY171555.
Hahn RA; MacDonald BR
J Pharmacol Exp Ther; 1984 Apr; 229(1):132-8. PubMed ID: 6707929
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of apomorphine and pergolide on neurogenic vasoconstriction in the hindquarters of the rat.
Dupont AG; Lefebvre RA; Bogaert MG
Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):146-51. PubMed ID: 4010793
[TBL] [Abstract][Full Text] [Related]
17. Selective activation by LY-141865 and apomorphine of presynaptic dopamine receptors in the rat kidney and influence of stimulation parameters in the action of dopamine.
Lokhandwala MF; Steenberg ML
J Pharmacol Exp Ther; 1984 Jan; 228(1):161-7. PubMed ID: 6694099
[TBL] [Abstract][Full Text] [Related]
18. Effects of dopamine (DA) and SKF 82526, a selective DA1-receptor agonist, on vascular resistances in the canine forelimb.
Grega GJ; Barrett RJ; Adamski SW; Lokhandwala MF
J Pharmacol Exp Ther; 1984 Jun; 229(3):756-62. PubMed ID: 6144791
[TBL] [Abstract][Full Text] [Related]
19. Effects of pergolide, a dopamine receptor agonist, and clonidine on cardiovascular responses evoked by activation of peripheral sympathetic outflow in rats.
Cavero I
Clin Exp Hypertens A; 1982; 4(1-2):221-33. PubMed ID: 7074987
[TBL] [Abstract][Full Text] [Related]
20. Effects of pergolide on the cardiovascular responses to sinoaortic deafferentation in dogs with intact or surgically decentralized adrenal glands.
Lorrain J; Donato Di Paola E; Lhoste F; Cavero I
J Pharmacol Exp Ther; 1987 Jan; 240(1):288-93. PubMed ID: 3806390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]